DRIO (DarioHealth) Tariff Resilience Score: 5/10 (As of Jul. 06, 2026)


DRIO DarioHealth Corp DRIO
62 GF Score
Price $7.26
GF Value $7.09
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is DarioHealth Tariff Resilience Score?

DarioHealth DRIO +7.85% 62 Tariff Resilience Score is 5 as of Jul. 06, 2026. GuruFocus rates DRIO with a GF Score™ of 62/100 and a GF Value™ of $7.09 (Fairly Valued). The stock has 4 warning signs investors should review. Among 672 Healthcare Providers & Services companies, DarioHealth ranks better than 79.32% on this metric.

DarioHealth has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

DarioHealth has DarioHealth relies on international suppliers for its health tech products, exposing it to tariff risks. However, its digital health focus allows some flexibility in sourcing and pricing. Previous tariffs have affected costs, but strategic supplier diversification is a mitigation strategy.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes DarioHealth might have Average Resilient.

DarioHealth  (NAS:DRIO) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

DarioHealth Tariff Resilience Score Related Terms

DRIO vs BEAT, ONMD, CRVW: Tariff Resilience Score Comparison

For the Health Information Services subindustry, DarioHealth's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DarioHealth Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where DarioHealth's Tariff Resilience Score falls into.


DRIO
62GF Score
DarioHealth Corp DRIO
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
DarioHealth (DRIO) has a Tariff Resilience Score of 5 as of Jul. 06, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, DarioHealth ranks #139 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 20.7%.
Is DarioHealth's Tariff Resilience Score too high?
DarioHealth's current Tariff Resilience Score is 5. Based on the distribution chart, DarioHealth ranks #139 out of 672 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DarioHealth has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's Tariff Resilience Score compare to BEAT and ONMD?
According to the Healthcare Providers & Services industry distribution chart, DarioHealth ranks #139 out of 672 companies for Tariff Resilience Score. This places DarioHealth in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. DarioHealth's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Fairly Valued. The stock's GF Value™ is $7.09, compared to a current price of $7.26 — trading 2.3% above its estimated fair value. The current Tariff Resilience Score is 5. DarioHealth's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For DarioHealth (DRIO), the current Tariff Resilience Score is 5 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DarioHealth (DRIO) Overvalued in 2026?

Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued. The current stock price of $7.26 is trading 2.3% above its estimated GF Value™ of $7.09. GuruFocus considers DarioHealth to be Fairly Valued.

Key valuation signals for DRIO:

  • Tariff Resilience Score: 5
  • GF Value™: $7.09 vs. price of $7.26 (2.3% above fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DarioHealth Business Description

Address 322 West 57th Street, New York, NY, USA, 10019
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
62GF Score

Get the complete analysis for DRIO

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.26
Price
$7.09
GF Value